Accordingly, analysis of RNA sequencing data from 1100 breast cancer patients in the TCGA demonstrates that high levels of PERK, which phosphorylates eIF2α during the ISR, are predictive of poor survival for 10 years following diagnosis with a hazard ratio of ~1.8 (Fig. 6k). The gene discussed is EIF2A; the disease is breast carcinoma.